Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2112217296', 'doi': 'https://doi.org/10.1007/s00280-013-2339-y', 'title': 'A phase 1b clinical trial of the multi-targeted tyrosine kinase inhibitor lenvatinib (E7080) in combination with everolimus for treatment of metastatic renal cell carcinoma (RCC)', 'display_name': 'A phase 1b clinical trial of the multi-targeted tyrosine kinase inhibitor lenvatinib (E7080) in combination with everolimus for treatment of metastatic renal cell carcinoma (RCC)', 'publication_year': 2013, 'publication_date': '2013-11-04', 'ids': {'openalex': 'https://openalex.org/W2112217296', 'doi': 'https://doi.org/10.1007/s00280-013-2339-y', 'mag': '2112217296', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/24190702', 'pmcid': 'https://www.ncbi.nlm.nih.gov/pmc/articles/3889692'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1007/s00280-013-2339-y', 'pdf_url': 'https://link.springer.com/content/pdf/10.1007/s00280-013-2339-y.pdf', 'source': {'id': 'https://openalex.org/S117498271', 'display_name': 'Cancer Chemotherapy and Pharmacology', 'issn_l': '0344-5704', 'issn': ['0344-5704', '1432-0843'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310319900', 'host_organization_name': 'Springer Science+Business Media', 'host_organization_lineage': ['https://openalex.org/P4310319965', 'https://openalex.org/P4310319900'], 'host_organization_lineage_names': ['Springer Nature', 'Springer Science+Business Media'], 'type': 'journal'}, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'hybrid', 'oa_url': 'https://link.springer.com/content/pdf/10.1007/s00280-013-2339-y.pdf', 'any_repository_has_fulltext': True}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5009190675', 'display_name': 'Ana M. Molina', 'orcid': 'https://orcid.org/0000-0003-2025-9418'}, 'institutions': [{'id': 'https://openalex.org/I1334819555', 'display_name': 'Memorial Sloan Kettering Cancer Center', 'ror': 'https://ror.org/02yrq0923', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1334819555']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Ana M. Molina', 'raw_affiliation_strings': ['Memorial Sloan-Kettering Cancer Center New York USA'], 'affiliations': [{'raw_affiliation_string': 'Memorial Sloan-Kettering Cancer Center New York USA', 'institution_ids': ['https://openalex.org/I1334819555']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5102785664', 'display_name': 'Thomas Powles', 'orcid': 'https://orcid.org/0000-0002-4529-4212'}, 'institutions': [{'id': 'https://openalex.org/I2800124591', 'display_name': 'Texas Oncology', 'ror': 'https://ror.org/02ketev28', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I2800124591']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Thomas E. Hutson', 'raw_affiliation_strings': ['Texas Oncology, Dallas, USA'], 'affiliations': [{'raw_affiliation_string': 'Texas Oncology, Dallas, USA', 'institution_ids': ['https://openalex.org/I2800124591']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5076054848', 'display_name': 'James Larkin', 'orcid': 'https://orcid.org/0000-0001-5569-9523'}, 'institutions': [{'id': 'https://openalex.org/I1325846038', 'display_name': 'Royal Marsden NHS Foundation Trust', 'ror': 'https://ror.org/0008wzh48', 'country_code': 'GB', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1325846038']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'James Larkin', 'raw_affiliation_strings': ['The Royal Marsden Hospital,London,UK.'], 'affiliations': [{'raw_affiliation_string': 'The Royal Marsden Hospital,London,UK.', 'institution_ids': ['https://openalex.org/I1325846038']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5076083068', 'display_name': 'Anne Gold', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210151718', 'display_name': 'Eisai (United States)', 'ror': 'https://ror.org/0469x1750', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210151718', 'https://openalex.org/I55881946']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Anne M. Gold', 'raw_affiliation_strings': ['Eisai Inc., Woodcliff Lake, USA'], 'affiliations': [{'raw_affiliation_string': 'Eisai Inc., Woodcliff Lake, USA', 'institution_ids': ['https://openalex.org/I4210151718']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5100890862', 'display_name': 'Karen Wood', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210148122', 'display_name': 'Eisai (United Kingdom)', 'ror': 'https://ror.org/054j7wb83', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I4210148122', 'https://openalex.org/I55881946']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Karen Wood', 'raw_affiliation_strings': ['Eisai Ltd. Hatfield, Hertfordshire UK'], 'affiliations': [{'raw_affiliation_string': 'Eisai Ltd. Hatfield, Hertfordshire UK', 'institution_ids': ['https://openalex.org/I4210148122']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5085818660', 'display_name': 'Dave Carter', 'orcid': 'https://orcid.org/0000-0003-3503-7615'}, 'institutions': [{'id': 'https://openalex.org/I4210148122', 'display_name': 'Eisai (United Kingdom)', 'ror': 'https://ror.org/054j7wb83', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I4210148122', 'https://openalex.org/I55881946']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Dave Carter', 'raw_affiliation_strings': ['Eisai Ltd. Hatfield, Hertfordshire UK'], 'affiliations': [{'raw_affiliation_string': 'Eisai Ltd. Hatfield, Hertfordshire UK', 'institution_ids': ['https://openalex.org/I4210148122']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5059063118', 'display_name': 'Robert J. Motzer', 'orcid': 'https://orcid.org/0000-0001-6925-2327'}, 'institutions': [{'id': 'https://openalex.org/I1334819555', 'display_name': 'Memorial Sloan Kettering Cancer Center', 'ror': 'https://ror.org/02yrq0923', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1334819555']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Robert Motzer', 'raw_affiliation_strings': ['Memorial Sloan-Kettering Cancer Center New York USA'], 'affiliations': [{'raw_affiliation_string': 'Memorial Sloan-Kettering Cancer Center New York USA', 'institution_ids': ['https://openalex.org/I1334819555']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5028789952', 'display_name': 'M. Dror Michaelson', 'orcid': 'https://orcid.org/0000-0001-9249-6338'}, 'institutions': [{'id': 'https://openalex.org/I4210087915', 'display_name': 'Massachusetts General Hospital', 'ror': 'https://ror.org/002pd6e78', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210087915', 'https://openalex.org/I48633490']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'M. Dror Michaelson', 'raw_affiliation_strings': ['Massachusetts General Hospital, Cancer Center, Boston, USA'], 'affiliations': [{'raw_affiliation_string': 'Massachusetts General Hospital, Cancer Center, Boston, USA', 'institution_ids': ['https://openalex.org/I4210087915']}]}], 'institution_assertions': [], 'countries_distinct_count': 2, 'institutions_distinct_count': 6, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': {'value': 3290, 'currency': 'EUR', 'value_usd': 3990, 'provenance': 'doaj'}, 'apc_paid': {'value': 3290, 'currency': 'EUR', 'value_usd': 3990, 'provenance': 'doaj'}, 'fwci': 6.881, 'has_fulltext': True, 'fulltext_origin': 'pdf', 'cited_by_count': 86, 'citation_normalized_percentile': {'value': 0.947333, 'is_in_top_1_percent': False, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 97, 'max': 98}, 'biblio': {'volume': '73', 'issue': '1', 'first_page': '181', 'last_page': '189'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10449', 'display_name': 'Renal Cell Carcinoma', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10449', 'display_name': 'Renal Cell Carcinoma', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12049', 'display_name': 'Tuberous Sclerosis Complex and Related Disorders', 'score': 0.9978, 'subfield': {'id': 'https://openalex.org/subfields/2737', 'display_name': 'Physiology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12140', 'display_name': 'Molecular Mechanisms of Kidney Development and Disease', 'score': 0.9966, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/lenvatinib', 'display_name': 'Lenvatinib', 'score': 0.9836302}, {'id': 'https://openalex.org/keywords/everolimus', 'display_name': 'Everolimus', 'score': 0.95289314}, {'id': 'https://openalex.org/keywords/mucositis', 'display_name': 'Mucositis', 'score': 0.4981737}, {'id': 'https://openalex.org/keywords/renal-cell-carcinoma', 'display_name': 'Renal Cell Carcinoma', 'score': 0.484274}, {'id': 'https://openalex.org/keywords/cabozantinib', 'display_name': 'Cabozantinib', 'score': 0.46208996}, {'id': 'https://openalex.org/keywords/tolerability', 'display_name': 'Tolerability', 'score': 0.45698336}], 'concepts': [{'id': 'https://openalex.org/C2776264508', 'wikidata': 'https://www.wikidata.org/wiki/Q6523413', 'display_name': 'Lenvatinib', 'level': 4, 'score': 0.9836302}, {'id': 'https://openalex.org/C2779699572', 'wikidata': 'https://www.wikidata.org/wiki/Q421052', 'display_name': 'Everolimus', 'level': 2, 'score': 0.95289314}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.85781217}, {'id': 'https://openalex.org/C2777472916', 'wikidata': 'https://www.wikidata.org/wiki/Q1164529', 'display_name': 'Renal cell carcinoma', 'level': 2, 'score': 0.7322827}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.61865604}, {'id': 'https://openalex.org/C2779490328', 'wikidata': 'https://www.wikidata.org/wiki/Q417542', 'display_name': 'Sunitinib', 'level': 3, 'score': 0.6143481}, {'id': 'https://openalex.org/C197934379', 'wikidata': 'https://www.wikidata.org/wiki/Q2047938', 'display_name': 'Adverse effect', 'level': 2, 'score': 0.5617751}, {'id': 'https://openalex.org/C2778820342', 'wikidata': 'https://www.wikidata.org/wiki/Q906415', 'display_name': 'Tyrosine-kinase inhibitor', 'level': 3, 'score': 0.5529278}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.5385991}, {'id': 'https://openalex.org/C2778496288', 'wikidata': 'https://www.wikidata.org/wiki/Q6931269', 'display_name': 'Mucositis', 'level': 3, 'score': 0.4981737}, {'id': 'https://openalex.org/C2781064419', 'wikidata': 'https://www.wikidata.org/wiki/Q795057', 'display_name': 'Cabozantinib', 'level': 3, 'score': 0.46208996}, {'id': 'https://openalex.org/C2778375690', 'wikidata': 'https://www.wikidata.org/wiki/Q7814214', 'display_name': 'Tolerability', 'level': 3, 'score': 0.45698336}, {'id': 'https://openalex.org/C2778695046', 'wikidata': 'https://www.wikidata.org/wiki/Q421136', 'display_name': 'Sorafenib', 'level': 3, 'score': 0.3891629}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.3864414}, {'id': 'https://openalex.org/C29730261', 'wikidata': 'https://www.wikidata.org/wiki/Q274160', 'display_name': 'Toxicity', 'level': 2, 'score': 0.29875204}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.24570754}, {'id': 'https://openalex.org/C2778019345', 'wikidata': 'https://www.wikidata.org/wiki/Q1148337', 'display_name': 'Hepatocellular carcinoma', 'level': 2, 'score': 0.05708942}], 'mesh': [{'descriptor_ui': 'D000971', 'descriptor_name': 'Antineoplastic Combined Chemotherapy Protocols', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D002292', 'descriptor_name': 'Carcinoma, Renal Cell', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D007680', 'descriptor_name': 'Kidney Neoplasms', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D000368', 'descriptor_name': 'Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000971', 'descriptor_name': 'Antineoplastic Combined Chemotherapy Protocols', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002292', 'descriptor_name': 'Carcinoma, Renal Cell', 'qualifier_ui': 'Q000556', 'qualifier_name': 'secondary', 'is_major_topic': False}, {'descriptor_ui': 'D002292', 'descriptor_name': 'Carcinoma, Renal Cell', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000068338', 'descriptor_name': 'Everolimus', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007680', 'descriptor_name': 'Kidney Neoplasms', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D020714', 'descriptor_name': 'Maximum Tolerated Dose', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008875', 'descriptor_name': 'Middle Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010671', 'descriptor_name': 'Phenylurea Compounds', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D010671', 'descriptor_name': 'Phenylurea Compounds', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D010671', 'descriptor_name': 'Phenylurea Compounds', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011804', 'descriptor_name': 'Quinolines', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D011804', 'descriptor_name': 'Quinolines', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D011804', 'descriptor_name': 'Quinolines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D020123', 'descriptor_name': 'Sirolimus', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D020123', 'descriptor_name': 'Sirolimus', 'qualifier_ui': 'Q000031', 'qualifier_name': 'analogs & derivatives', 'is_major_topic': False}, {'descriptor_ui': 'D020123', 'descriptor_name': 'Sirolimus', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D020123', 'descriptor_name': 'Sirolimus', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 4, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1007/s00280-013-2339-y', 'pdf_url': 'https://link.springer.com/content/pdf/10.1007/s00280-013-2339-y.pdf', 'source': {'id': 'https://openalex.org/S117498271', 'display_name': 'Cancer Chemotherapy and Pharmacology', 'issn_l': '0344-5704', 'issn': ['0344-5704', '1432-0843'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310319900', 'host_organization_name': 'Springer Science+Business Media', 'host_organization_lineage': ['https://openalex.org/P4310319965', 'https://openalex.org/P4310319900'], 'host_organization_lineage_names': ['Springer Nature', 'Springer Science+Business Media'], 'type': 'journal'}, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://europepmc.org/articles/pmc3889692', 'pdf_url': 'https://europepmc.org/articles/pmc3889692?pdf=render', 'source': {'id': 'https://openalex.org/S4306400806', 'display_name': 'Europe PMC (PubMed Central)', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1303153112', 'host_organization_name': 'European Bioinformatics Institute', 'host_organization_lineage': ['https://openalex.org/I1303153112'], 'host_organization_lineage_names': ['European Bioinformatics Institute'], 'type': 'repository'}, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889692', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764455111', 'display_name': 'PubMed Central', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/24190702', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1007/s00280-013-2339-y', 'pdf_url': 'https://link.springer.com/content/pdf/10.1007/s00280-013-2339-y.pdf', 'source': {'id': 'https://openalex.org/S117498271', 'display_name': 'Cancer Chemotherapy and Pharmacology', 'issn_l': '0344-5704', 'issn': ['0344-5704', '1432-0843'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310319900', 'host_organization_name': 'Springer Science+Business Media', 'host_organization_lineage': ['https://openalex.org/P4310319965', 'https://openalex.org/P4310319900'], 'host_organization_lineage_names': ['Springer Nature', 'Springer Science+Business Media'], 'type': 'journal'}, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'score': 0.78, 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 33, 'referenced_works': ['https://openalex.org/W1940998999', 'https://openalex.org/W1976033646', 'https://openalex.org/W1999966467', 'https://openalex.org/W2010133921', 'https://openalex.org/W2014582878', 'https://openalex.org/W2019294726', 'https://openalex.org/W2019607817', 'https://openalex.org/W2021681883', 'https://openalex.org/W2023952988', 'https://openalex.org/W2024586523', 'https://openalex.org/W2027156097', 'https://openalex.org/W2028690273', 'https://openalex.org/W2062997257', 'https://openalex.org/W2071263415', 'https://openalex.org/W2075997152', 'https://openalex.org/W2080726748', 'https://openalex.org/W2087137617', 'https://openalex.org/W2090310262', 'https://openalex.org/W2095370944', 'https://openalex.org/W2107054830', 'https://openalex.org/W2108606306', 'https://openalex.org/W2112015830', 'https://openalex.org/W2129820508', 'https://openalex.org/W2138129102', 'https://openalex.org/W2146711059', 'https://openalex.org/W2156408558', 'https://openalex.org/W2157262448', 'https://openalex.org/W2162424705', 'https://openalex.org/W2164638888', 'https://openalex.org/W2170494050', 'https://openalex.org/W2278754305', 'https://openalex.org/W2507114078', 'https://openalex.org/W2602538527'], 'related_works': ['https://openalex.org/W4361887559', 'https://openalex.org/W4214548184', 'https://openalex.org/W4210780560', 'https://openalex.org/W2793316388', 'https://openalex.org/W2744961912', 'https://openalex.org/W2560068745', 'https://openalex.org/W2416477273', 'https://openalex.org/W2241969517', 'https://openalex.org/W2035240798', 'https://openalex.org/W1975744019'], 'abstract_inverted_index': {'Lenvatinib': [0, 224], 'is': [1, 16], 'an': [2, 17, 111], 'oral': [3, 18], 'multi-targeted': [4], 'tyrosine': [5], 'kinase': [6], 'inhibitor': [7, 23], 'of': [8, 21, 45, 71, 206, 251], 'VEGFR1-3,': [9], 'FGFR1-4,': [10], 'PDGFRβ,': [11], 'RET,': [12], 'and': [13, 41, 60, 191, 198, 209, 218, 241], 'KIT.': [14], 'Everolimus': [15], 'mammalian': [19], 'target': [20], 'rapamycin': [22], 'approved': [24], 'for': [25], 'advanced': [26, 56, 255], 'renal': [27], 'cell': [28], 'carcinoma': [29], '(RCC).': [30], 'This': [31], 'phase': [32], '1b': [33], 'study': [34], 'assessed': [35], 'safety,': [36], 'maximum': [37], 'tolerated': [38], 'dose': [39, 77], '(MTD),': [40], 'preliminary': [42], 'antitumor': [43], 'activity': [44, 247], 'lenvatinib': [46, 79, 120, 146], 'plus': [47, 136, 149], 'everolimus': [48, 85, 137, 150, 229], 'in': [49, 92, 110, 214, 254], 'metastatic': [50], 'RCC': [51, 256], '(mRCC)': [52], 'patients.': [53, 257], 'Patients': [54], 'with': [55, 84, 228, 234, 238], 'unresectable': [57], 'or': [58], 'mRCC': [59], 'Eastern': [61], 'Cooperative': [62], 'Oncology': [63], 'Group': [64], 'performance': [65], 'status': [66], '0–1': [67], 'were': [68, 108, 163, 212], 'eligible': [69], '(number': [70], 'prior': [72], 'treatments': [73], 'not': [74], 'restricted).': [75], 'Starting': [76], 'was': [78, 141, 232], '12': [80], 'mg': [81, 87, 122, 127, 132, 148, 226, 231], 'once': [82, 88, 144], 'daily': [83, 89, 145], '5': [86, 138, 151, 188, 230], 'administered': [90], 'continuously': [91], '28-day': [93], 'cycles': [94], 'using': [95], 'a': [96], 'conventional': [97], '3': [98, 100], '+': [99], 'dose-escalation': [101], 'design.': [102], 'At': [103], 'the': [104, 252], 'MTD,': [105], 'additional': [106], 'patients': [107, 115], 'enrolled': [109], 'expansion': [112], 'cohort.': [113], 'Twenty': [114], '(mean': [116], '58.4': [117], 'years)': [118], 'received': [119], '[12': [121], '(n': [123, 128, 133, 201], '=': [124, 129, 134, 202], '7);': [125], '18': [126, 147, 225], '11);': [130], '24': [131], '2)]': [135], 'mg.': [139, 152], 'MTD': [140, 197], 'established': [142], 'as': [143], 'The': [153], 'most': [154], 'common': [155], 'treatment-related': [156], 'treatment-emergent': [157], 'adverse': [158], 'events': [159], '(all': [160], 'dosing': [161], 'cohorts)': [162], 'fatigue': [164], '60': [165], '%': [166], '(Grade': [167, 176, 181, 186], '≥3:': [168, 177, 182, 187], '10': [169, 183], '%),': [170, 179, 184, 189], 'mucosal': [171], 'inflammation': [172], '50': [173], '%,': [174], 'proteinuria': [175], '15': [178], 'diarrhea': [180], 'vomiting': [185], 'hypertension,': [190], 'nausea,': [192], 'each': [193], '40': [194], '%.': [195], 'In': [196], 'lowest-dose': [199], 'cohorts': [200], '18),': [203], 'best': [204], 'responses': [205], 'partial': [207], 'response': [208], 'stable': [210], 'disease': [211], 'achieved': [213], '6': [215], '(33': [216], '%)': [217, 221], '9': [219], '(50': [220], 'patients,': [222], 'respectively.': [223], 'combined': [227], 'associated': [233], 'manageable': [235], 'toxicity': [236], 'consistent': [237], 'individual': [239], 'agents': [240], 'no': [242], 'new': [243], 'safety': [244], 'signals.': [245], 'Observed': [246], 'warrants': [248], 'further': [249], 'evaluation': [250], 'combination': [253]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2112217296', 'counts_by_year': [{'year': 2024, 'cited_by_count': 4}, {'year': 2023, 'cited_by_count': 5}, {'year': 2022, 'cited_by_count': 2}, {'year': 2021, 'cited_by_count': 8}, {'year': 2020, 'cited_by_count': 7}, {'year': 2019, 'cited_by_count': 8}, {'year': 2018, 'cited_by_count': 7}, {'year': 2017, 'cited_by_count': 16}, {'year': 2016, 'cited_by_count': 10}, {'year': 2015, 'cited_by_count': 10}, {'year': 2014, 'cited_by_count': 8}], 'updated_date': '2024-09-25T06:25:29.387195', 'created_date': '2016-06-24'}